© C McNab

Background papers

Background Paper 6: Scaling-up Vaccine Production Capacity: Legal Challenges and Recommendations

This paper examines the legal dimensions of scaling up vaccine production by entities and countries that don’t hold intellectual property rights. It examines issues such as TRIPS waivers and the role of intellectual property in scaling up production. May 2021.

Background Paper 6: Scaling-up Vaccine Production Capacity: Legal Challenges and Recommendations Read More »

Scroll to Top